PRECEDO PHARMACEUTICALS CO LTD has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SHOUYAO HOLDINGS BEIJING CO LTD, REVOLUTION MEDICINES INC and CAPULUS THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Wang Wenchao | 13 |
#2 | Wang Aoli | 13 |
#3 | Wang Beilei | 13 |
#4 | Wang Li | 13 |
#5 | Liu Jing | 13 |
#6 | Liu Qingsong | 13 |
#7 | Qi Ziping | 12 |
#8 | Wu Hong | 10 |
#9 | Chen Cheng | 10 |
#10 | Hu Chen | 10 |
Publication | Filing date | Title |
---|---|---|
US2020010471A1 | Inhibitor of FLT3 kinase and use thereof | |
EP3438094A1 | Selective c-kit kinase inhibitor | |
US2019010159A1 | Kinase inhibitor against wild-type and mutant EGFR | |
EP3392245A1 | Novel egfr and alk dual inhibitor | |
WO2017049462A1 | Novel flt3 kinase inhibitor and uses thereof |